$AWH, $AGRX, $RDUS Propel Women's Health Sector with Remarkable +14.83% Weekly Performance Surge
Robots for this group tickers :
Day Trader, Popular Stocks: Price Action Trading Strategy (TA&FA) - 30-day Annualized Return +209%
Swing Trader, Popular Stocks: Price Action Trading Strategy - Pro Version (TA&FA) - 30-day Annualized Return +182%
Recently, Women's Health companies have taken center stage, showcasing a remarkable +14.83% increase in performance over the past week. This surge is backed by three key players in the sector - AWH (Aspira Women's Health), AGRX (Agile Therapeutics), and RDUS (Radius Health).
Positive Outlook and Volume Indicators: Today, stocks in the Women's Health group maintain a positive outlook, supported by robust Volume Indicators. Tickeron, a leading market analysis platform, predicts a further increase of over 4.00% within the next month, with a 63% likelihood. The daily ratio of advancing to declining volumes in the past month was an impressive 4.35 to 1.
Advances Indicator and Positive Trends: A closer look at the Advances Indicator reveals a consistent positive trend across three stocks in this thematic group, with an average likelihood of 82%. This suggests a prevailing sentiment of growth and stability among investors.
Market Capitalization Insights: The market capitalization within the Women's Health Theme averages at 245.7M. RDUS stands out with the highest valuation in this group, reaching an impressive 697.4M. In contrast, AGRX holds the position of the lowest valued company at 5.2M.
Price Movements: Weekly, the average price growth for all stocks in the Women's Health Theme was a significant 14.83%. AWH spearheaded this growth with a remarkable 43.89% increase, while AGRX experienced a notable dip at -2.99%. The monthly and quarterly averages stood at 10.55% and -4.59%, respectively.
Notable News and Price Movements:
- AWH made headlines as the top weekly gainer, rising by 26.79% on 8/15/23, and also faced a significant drop of -36.68% on 7/27/23.
- AGRX, on 10/7/23, saw a sharp decline of -20.83%, marking it as a top weekly loser.
- RDUS, on 12/26/23, continued an uptrend, experiencing a +22% increase during the month of 11/22/23 - 12/26/23.
Volume Growth: While the average weekly volume growth across all stocks in the Women's Health Theme was -1.08%, monthly and quarterly figures painted a different picture with 164.37% and 19.64% growth, respectively. Notable record-breaking daily volume increases were observed for AWH, AGRX, and RDUS, emphasizing heightened market activity.
Technical Analysis Highlights:
-
AWH: The 50-day moving average crossed bearishly below the 200-day moving average on December 11, 2023. Despite this, the stock has shown resilience, with a recent uptrend of +28% during the week of 12/18/23 - 12/26/23.
-
AGRX: The RSI Oscillator for AGRX moved out of the overbought zone on December 05, 2023, suggesting a potential shift from an upward to a downward trend. The odds of a move down, according to Tickeron's analysis, stand at 90%.
-
RDUS: Displaying a +1.52% uptrend, RDUS advanced for three consecutive days on December 26, 2023. Historical data indicates a 75% likelihood of continued upward momentum.
Summary: The Women's Health sector, led by AWH, AGRX, and RDUS, is currently in a phase of dynamic growth, supported by positive market indicators and technical analyses. Investors should keep a keen eye on these stocks, considering the theme's potential for further expansion in the coming months.
AWH's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for AWH turned positive on February 24, 2025. Looking at past instances where AWH's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AWH's RSI Oscillator exited the oversold zone, of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 66 cases where AWH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where AWH advanced for three days, in of 249 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AWH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for AWH entered a downward trend on March 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (35.971) is normal, around the industry mean (23.715). P/E Ratio (0.000) is within average values for comparable stocks, (83.458). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.527) is also within normal values, averaging (41.612).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. AWH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AWH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
General Information
a company, which engages in the provision of bio-analytic and diagnostic services and helps physicians diagnose, treat, and improve gynecologic health outcomes for women
Industry MedicalSpecialties